

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.60387012 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 6.18366202 |
| 3 | viral transcription (GO:0019083) | 5.37041243 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.36420336 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.15366563 |
| 6 | negative regulation of cell killing (GO:0031342) | 5.15366563 |
| 7 | translational termination (GO:0006415) | 5.07639277 |
| 8 | DNA deamination (GO:0045006) | 4.96098073 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.92060157 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.92060157 |
| 11 | ribosomal small subunit biogenesis (GO:0042274) | 4.59881768 |
| 12 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.51926098 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.45598966 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.45598966 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 4.45598966 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 4.45598966 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.45598966 |
| 18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.45598966 |
| 19 | cotranslational protein targeting to membrane (GO:0006613) | 4.40481995 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.39596198 |
| 21 | protein targeting to ER (GO:0045047) | 4.38511921 |
| 22 | translational elongation (GO:0006414) | 4.31958441 |
| 23 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.30067406 |
| 24 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.22508275 |
| 25 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.22431435 |
| 26 | response to interferon-beta (GO:0035456) | 4.19146925 |
| 27 | protein localization to endoplasmic reticulum (GO:0070972) | 4.17700397 |
| 28 | detection of other organism (GO:0098543) | 4.16918910 |
| 29 | neutrophil activation (GO:0042119) | 4.15889277 |
| 30 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.15868538 |
| 31 | detection of bacterium (GO:0016045) | 4.14881253 |
| 32 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.05002050 |
| 33 | positive regulation of mast cell activation (GO:0033005) | 3.99389430 |
| 34 | viral life cycle (GO:0019058) | 3.92048628 |
| 35 | platelet dense granule organization (GO:0060155) | 3.91357468 |
| 36 | macrophage activation involved in immune response (GO:0002281) | 3.89069098 |
| 37 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.81064988 |
| 38 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.80934366 |
| 39 | regulation of mast cell degranulation (GO:0043304) | 3.76468767 |
| 40 | cellular protein complex disassembly (GO:0043624) | 3.75602332 |
| 41 | granulocyte activation (GO:0036230) | 3.75438750 |
| 42 | definitive hemopoiesis (GO:0060216) | 3.69652673 |
| 43 | maturation of SSU-rRNA (GO:0030490) | 3.66983522 |
| 44 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.64993349 |
| 45 | cellular extravasation (GO:0045123) | 3.60079478 |
| 46 | regulation of platelet aggregation (GO:0090330) | 3.58343043 |
| 47 | positive regulation of B cell differentiation (GO:0045579) | 3.51988494 |
| 48 | mast cell activation (GO:0045576) | 3.48027631 |
| 49 | defense response to protozoan (GO:0042832) | 3.46168477 |
| 50 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.45869374 |
| 51 | myeloid cell activation involved in immune response (GO:0002275) | 3.45413359 |
| 52 | mature B cell differentiation involved in immune response (GO:0002313) | 3.44789513 |
| 53 | cellular response to interferon-beta (GO:0035458) | 3.41528513 |
| 54 | translational initiation (GO:0006413) | 3.41221454 |
| 55 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.39100634 |
| 56 | lymphoid progenitor cell differentiation (GO:0002320) | 3.38779745 |
| 57 | response to protozoan (GO:0001562) | 3.37331685 |
| 58 | detection of external biotic stimulus (GO:0098581) | 3.37105052 |
| 59 | regulation of mast cell activation (GO:0033003) | 3.34219273 |
| 60 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.31239185 |
| 61 | microglial cell activation (GO:0001774) | 3.29477480 |
| 62 | protein complex disassembly (GO:0043241) | 3.27630001 |
| 63 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.27073753 |
| 64 | negative regulation of interleukin-12 production (GO:0032695) | 3.27006701 |
| 65 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.26603330 |
| 66 | cellular response to type I interferon (GO:0071357) | 3.25318045 |
| 67 | type I interferon signaling pathway (GO:0060337) | 3.25318045 |
| 68 | regulation of leukocyte degranulation (GO:0043300) | 3.25139040 |
| 69 | response to type I interferon (GO:0034340) | 3.23878366 |
| 70 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.23303466 |
| 71 | response to host immune response (GO:0052572) | 3.23303466 |
| 72 | immunoglobulin mediated immune response (GO:0016064) | 3.21914020 |
| 73 | regulation of B cell differentiation (GO:0045577) | 3.21742503 |
| 74 | mature B cell differentiation (GO:0002335) | 3.19957207 |
| 75 | leukocyte degranulation (GO:0043299) | 3.15228013 |
| 76 | thrombin receptor signaling pathway (GO:0070493) | 3.13714211 |
| 77 | positive regulation of mast cell degranulation (GO:0043306) | 3.13691964 |
| 78 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.13691964 |
| 79 | germinal center formation (GO:0002467) | 3.13058882 |
| 80 | ribosomal large subunit biogenesis (GO:0042273) | 3.12765610 |
| 81 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.11993668 |
| 82 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.10114991 |
| 83 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.09299628 |
| 84 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.06163737 |
| 85 | positive thymic T cell selection (GO:0045059) | 3.04308008 |
| 86 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.03812510 |
| 87 | macromolecular complex disassembly (GO:0032984) | 3.03766391 |
| 88 | response to interferon-alpha (GO:0035455) | 3.02434074 |
| 89 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.01958293 |
| 90 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.01958293 |
| 91 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.01116198 |
| 92 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.00656717 |
| 93 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.00583813 |
| 94 | response to host (GO:0075136) | 2.99672189 |
| 95 | response to host defenses (GO:0052200) | 2.99672189 |
| 96 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.99672189 |
| 97 | T cell homeostasis (GO:0043029) | 2.99013524 |
| 98 | negative thymic T cell selection (GO:0045060) | 2.96963795 |
| 99 | myeloid dendritic cell activation (GO:0001773) | 2.96801842 |
| 100 | negative regulation of phagocytosis (GO:0050765) | 2.95874501 |
| 101 | detection of biotic stimulus (GO:0009595) | 2.94504017 |
| 102 | lymph node development (GO:0048535) | 2.94416089 |
| 103 | tolerance induction (GO:0002507) | 2.93663022 |
| 104 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.92255798 |
| 105 | regulation of gamma-delta T cell activation (GO:0046643) | 2.92055561 |
| 106 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.91388661 |
| 107 | T cell selection (GO:0045058) | 2.90562976 |
| 108 | B cell receptor signaling pathway (GO:0050853) | 2.89158830 |
| 109 | macrophage activation (GO:0042116) | 2.89047298 |
| 110 | negative T cell selection (GO:0043383) | 2.88116158 |
| 111 | actin filament polymerization (GO:0030041) | 2.88088955 |
| 112 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.88086097 |
| 113 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.87828282 |
| 114 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.87823597 |
| 115 | megakaryocyte development (GO:0035855) | 2.87322507 |
| 116 | detection of molecule of bacterial origin (GO:0032490) | 2.83192568 |
| 117 | regulation of platelet activation (GO:0010543) | 2.82164894 |
| 118 | mRNA catabolic process (GO:0006402) | 2.81324895 |
| 119 | interferon-gamma production (GO:0032609) | 2.79714391 |
| 120 | endosome to pigment granule transport (GO:0043485) | 2.78636434 |
| 121 | endosome to melanosome transport (GO:0035646) | 2.78636434 |
| 122 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.78512654 |
| 123 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.78512654 |
| 124 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.77991813 |
| 125 | dendritic cell chemotaxis (GO:0002407) | 2.77650823 |
| 126 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.76210001 |
| 127 | regulation of tolerance induction (GO:0002643) | 2.76111874 |
| 128 | protein targeting to membrane (GO:0006612) | 2.75763242 |
| 129 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.75378145 |
| 130 | regulation of regulated secretory pathway (GO:1903305) | 2.75178831 |
| 131 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.75095885 |
| 132 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.74704307 |
| 133 | telomere maintenance via recombination (GO:0000722) | 2.74396088 |
| 134 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.73228669 |
| 135 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.73180706 |
| 136 | negative regulation of T cell mediated immunity (GO:0002710) | 2.71695329 |
| 137 | regulation of T cell tolerance induction (GO:0002664) | 2.71445719 |
| 138 | secretory granule organization (GO:0033363) | 2.70538619 |
| 139 | mast cell degranulation (GO:0043303) | 2.70486174 |
| 140 | mast cell activation involved in immune response (GO:0002279) | 2.70486174 |
| 141 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.70224764 |
| 142 | positive regulation of B cell mediated immunity (GO:0002714) | 2.70224764 |
| 143 | positive regulation of granulocyte differentiation (GO:0030854) | 2.68344861 |
| 144 | B cell mediated immunity (GO:0019724) | 2.66348253 |
| 145 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.66262266 |
| 146 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.65609136 |
| 147 | RNA catabolic process (GO:0006401) | 2.65395333 |
| 148 | positive regulation of macrophage differentiation (GO:0045651) | 2.64542693 |
| 149 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.64060948 |
| 150 | positive regulation of antigen processing and presentation (GO:0002579) | 2.62585880 |
| 151 | negative regulation of granulocyte differentiation (GO:0030853) | 2.60534876 |
| 152 | leukocyte aggregation (GO:0070486) | 2.60527736 |
| 153 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.59898840 |
| 154 | regulation of respiratory burst (GO:0060263) | 2.58289774 |
| 155 | regulation of regulatory T cell differentiation (GO:0045589) | 2.57981907 |
| 156 | T cell migration (GO:0072678) | 2.56625773 |
| 157 | translation (GO:0006412) | 2.54159379 |
| 158 | cellular response to zinc ion (GO:0071294) | 2.54047071 |
| 159 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.51352338 |
| 160 | NIK/NF-kappaB signaling (GO:0038061) | 2.49827091 |
| 161 | DNA strand elongation (GO:0022616) | 2.49557016 |
| 162 | respiratory chain complex IV assembly (GO:0008535) | 2.49174266 |
| 163 | response to peptidoglycan (GO:0032494) | 2.48257631 |
| 164 | phospholipid scrambling (GO:0017121) | 2.45646951 |
| 165 | negative regulation of viral genome replication (GO:0045071) | 2.45449968 |
| 166 | cellular response to exogenous dsRNA (GO:0071360) | 2.45111217 |
| 167 | regulation of antigen processing and presentation (GO:0002577) | 2.44655597 |
| 168 | myeloid dendritic cell differentiation (GO:0043011) | 2.42383738 |
| 169 | respiratory burst (GO:0045730) | 2.42037240 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.40338913 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.12063286 |
| 3 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.75346277 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.69936771 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.35924527 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.26587611 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.25553668 |
| 8 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 3.11767691 |
| 9 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.09886594 |
| 10 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.05185878 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.92821472 |
| 12 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.87062323 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.82206120 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.78125042 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.76942672 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.64836974 |
| 17 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.56298011 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.46677807 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.46165147 |
| 20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.40355274 |
| 21 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.33575006 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.32432729 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.32346670 |
| 24 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.31644970 |
| 25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30459630 |
| 26 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.26527110 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 2.18536028 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.18460061 |
| 29 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.14159228 |
| 30 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10511841 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 2.07945069 |
| 32 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.06514220 |
| 33 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.04673106 |
| 34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04514032 |
| 35 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.97356787 |
| 36 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.93996315 |
| 37 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.93803741 |
| 38 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.93417771 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93344865 |
| 40 | GATA1_19941826_ChIP-Seq_K562_Human | 1.91503869 |
| 41 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.91320278 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.90630539 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.88793267 |
| 44 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.87819286 |
| 45 | MAF_26560356_Chip-Seq_TH1_Human | 1.83911147 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.82671251 |
| 47 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82633836 |
| 48 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.80320982 |
| 49 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.79801388 |
| 50 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.79405710 |
| 51 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.77967396 |
| 52 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.74795395 |
| 53 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.73591592 |
| 54 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.72297920 |
| 55 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.72247381 |
| 56 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.69171355 |
| 57 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.67196278 |
| 58 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.67061805 |
| 59 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.64471221 |
| 60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.63561353 |
| 61 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.61726994 |
| 62 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.61680435 |
| 63 | UTX_26944678_Chip-Seq_JUKART_Human | 1.61297160 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.60222603 |
| 65 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.59600706 |
| 66 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.55568235 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.55252259 |
| 68 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.53499873 |
| 69 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.53430131 |
| 70 | GATA2_19941826_ChIP-Seq_K562_Human | 1.50722420 |
| 71 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.50241053 |
| 72 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.45200787 |
| 73 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.43082572 |
| 74 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.42601972 |
| 75 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.42272992 |
| 76 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.40495137 |
| 77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39416984 |
| 78 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.38526143 |
| 79 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38465095 |
| 80 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.37943414 |
| 81 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.37469485 |
| 82 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.37261090 |
| 83 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.35979018 |
| 84 | MAF_26560356_Chip-Seq_TH2_Human | 1.34896129 |
| 85 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.33715348 |
| 86 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.32531805 |
| 87 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.30448437 |
| 88 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29056122 |
| 89 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.28033314 |
| 90 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.27928415 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.27911926 |
| 92 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27444521 |
| 93 | GATA1_22025678_ChIP-Seq_K562_Human | 1.24203155 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.23756313 |
| 95 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.22234469 |
| 96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21141855 |
| 97 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20817790 |
| 98 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.20740660 |
| 99 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20067077 |
| 100 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.19361717 |
| 101 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17164831 |
| 102 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15356945 |
| 103 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15057901 |
| 104 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.13417803 |
| 105 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12129528 |
| 106 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11526328 |
| 107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10905270 |
| 108 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.09290005 |
| 109 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.08028947 |
| 110 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.07279241 |
| 111 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06247674 |
| 112 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.05371921 |
| 113 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03497343 |
| 114 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00565732 |
| 115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00353692 |
| 116 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.00124778 |
| 117 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.99999967 |
| 118 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99315239 |
| 119 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99039794 |
| 120 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.99025253 |
| 121 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98026456 |
| 122 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97710648 |
| 123 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97430177 |
| 124 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.97376620 |
| 125 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97262977 |
| 126 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96446237 |
| 127 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96288892 |
| 128 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.95746743 |
| 129 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.95379054 |
| 130 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95340991 |
| 131 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.95160583 |
| 132 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95000122 |
| 133 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94436951 |
| 134 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93698241 |
| 135 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93173001 |
| 136 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.92335875 |
| 137 | P68_20966046_ChIP-Seq_HELA_Human | 0.91942240 |
| 138 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.91087080 |
| 139 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91042958 |
| 140 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90771448 |
| 141 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.90220361 |
| 142 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.90138436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.20297937 |
| 2 | MP0005671_abnormal_response_to | 3.45317049 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.35569895 |
| 4 | MP0009785_altered_susceptibility_to | 3.11790012 |
| 5 | MP0000685_abnormal_immune_system | 2.95428458 |
| 6 | MP0003763_abnormal_thymus_physiology | 2.93758323 |
| 7 | MP0001800_abnormal_humoral_immune | 2.69877389 |
| 8 | MP0005174_abnormal_tail_pigmentation | 2.66981582 |
| 9 | MP0005025_abnormal_response_to | 2.64264955 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.63995029 |
| 11 | MP0003724_increased_susceptibility_to | 2.62494193 |
| 12 | MP0001873_stomach_inflammation | 2.52470920 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.49717812 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.47924290 |
| 15 | MP0003436_decreased_susceptibility_to | 2.47580493 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.47238538 |
| 17 | MP0001819_abnormal_immune_cell | 2.44648024 |
| 18 | MP0002723_abnormal_immune_serum | 2.43854015 |
| 19 | MP0001790_abnormal_immune_system | 2.38714861 |
| 20 | MP0005387_immune_system_phenotype | 2.38714861 |
| 21 | MP0008004_abnormal_stomach_pH | 2.35374966 |
| 22 | MP0002398_abnormal_bone_marrow | 2.32372109 |
| 23 | MP0000490_abnormal_crypts_of | 2.30003742 |
| 24 | MP0000465_gastrointestinal_hemorrhage | 2.27701427 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.27483014 |
| 26 | MP0002419_abnormal_innate_immunity | 2.21879982 |
| 27 | MP0002166_altered_tumor_susceptibility | 2.21807670 |
| 28 | MP0005075_abnormal_melanosome_morpholog | 2.20109680 |
| 29 | MP0010155_abnormal_intestine_physiology | 2.17831776 |
| 30 | MP0009379_abnormal_foot_pigmentation | 2.14334771 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 2.11240566 |
| 32 | MP0004808_abnormal_hematopoietic_stem | 2.10979125 |
| 33 | MP0000716_abnormal_immune_system | 2.09544208 |
| 34 | MP0003866_abnormal_defecation | 2.01070985 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.99956413 |
| 36 | MP0002722_abnormal_immune_system | 1.92094935 |
| 37 | MP0002405_respiratory_system_inflammati | 1.88869278 |
| 38 | MP0001986_abnormal_taste_sensitivity | 1.86262052 |
| 39 | MP0001853_heart_inflammation | 1.85795191 |
| 40 | MP0002429_abnormal_blood_cell | 1.82999772 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.80614007 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.80614007 |
| 43 | MP0002006_tumorigenesis | 1.77973559 |
| 44 | MP0002095_abnormal_skin_pigmentation | 1.77108045 |
| 45 | MP0000015_abnormal_ear_pigmentation | 1.74569264 |
| 46 | MP0003693_abnormal_embryo_hatching | 1.60890450 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.60103143 |
| 48 | MP0001851_eye_inflammation | 1.59818228 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.54901694 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.45707342 |
| 51 | MP0006292_abnormal_olfactory_placode | 1.42862339 |
| 52 | MP0008058_abnormal_DNA_repair | 1.42680324 |
| 53 | MP0002132_abnormal_respiratory_system | 1.40757104 |
| 54 | MP0008260_abnormal_autophagy | 1.39581231 |
| 55 | MP0006082_CNS_inflammation | 1.38957237 |
| 56 | MP0005083_abnormal_biliary_tract | 1.33669465 |
| 57 | MP0008469_abnormal_protein_level | 1.22935569 |
| 58 | MP0008007_abnormal_cellular_replicative | 1.21870069 |
| 59 | MP0005451_abnormal_body_composition | 1.19018691 |
| 60 | MP0005409_darkened_coat_color | 1.18296321 |
| 61 | MP0001188_hyperpigmentation | 1.17846601 |
| 62 | MP0004883_abnormal_blood_vessel | 1.17722487 |
| 63 | MP0005310_abnormal_salivary_gland | 1.12625090 |
| 64 | MP0002933_joint_inflammation | 1.11959351 |
| 65 | MP0003075_altered_response_to | 1.11889696 |
| 66 | MP0001663_abnormal_digestive_system | 1.11035928 |
| 67 | MP0000858_altered_metastatic_potential | 1.10735248 |
| 68 | MP0002019_abnormal_tumor_incidence | 1.10260545 |
| 69 | MP0009278_abnormal_bone_marrow | 1.08573382 |
| 70 | MP0003303_peritoneal_inflammation | 1.08482386 |
| 71 | MP0001533_abnormal_skeleton_physiology | 1.08009857 |
| 72 | MP0004947_skin_inflammation | 1.07324820 |
| 73 | MP0005166_decreased_susceptibility_to | 1.02147071 |
| 74 | MP0004381_abnormal_hair_follicle | 1.01738868 |
| 75 | MP0002277_abnormal_respiratory_mucosa | 1.00949837 |
| 76 | MP0010094_abnormal_chromosome_stability | 1.00935515 |
| 77 | MP0000249_abnormal_blood_vessel | 0.99109960 |
| 78 | MP0009764_decreased_sensitivity_to | 0.94695282 |
| 79 | MP0004147_increased_porphyrin_level | 0.93802056 |
| 80 | MP0000372_irregular_coat_pigmentation | 0.92548900 |
| 81 | MP0005365_abnormal_bile_salt | 0.88793369 |
| 82 | MP0003077_abnormal_cell_cycle | 0.86163644 |
| 83 | MP0002138_abnormal_hepatobiliary_system | 0.85682775 |
| 84 | MP0000343_altered_response_to | 0.85671914 |
| 85 | MP0003879_abnormal_hair_cell | 0.85456108 |
| 86 | MP0003786_premature_aging | 0.84194601 |
| 87 | MP0008057_abnormal_DNA_replication | 0.84151173 |
| 88 | MP0003690_abnormal_glial_cell | 0.81017068 |
| 89 | MP0000477_abnormal_intestine_morphology | 0.80963398 |
| 90 | MP0004510_myositis | 0.80717026 |
| 91 | MP0003828_pulmonary_edema | 0.80306043 |
| 92 | MP0008874_decreased_physiological_sensi | 0.78800397 |
| 93 | MP0003566_abnormal_cell_adhesion | 0.78674131 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.78131186 |
| 95 | MP0005164_abnormal_response_to | 0.77979867 |
| 96 | MP0000681_abnormal_thyroid_gland | 0.77829961 |
| 97 | MP0004130_abnormal_muscle_cell | 0.75452318 |
| 98 | MP0002009_preneoplasia | 0.75280024 |
| 99 | MP0003045_fibrosis | 0.74938539 |
| 100 | MP0005390_skeleton_phenotype | 0.74124945 |
| 101 | MP0003943_abnormal_hepatobiliary_system | 0.73532810 |
| 102 | MP0003300_gastrointestinal_ulcer | 0.73501383 |
| 103 | MP0006054_spinal_hemorrhage | 0.72210095 |
| 104 | MP0005058_abnormal_lysosome_morphology | 0.71863070 |
| 105 | MP0008995_early_reproductive_senescence | 0.71611931 |
| 106 | MP0000313_abnormal_cell_death | 0.70586508 |
| 107 | MP0003795_abnormal_bone_structure | 0.69156892 |
| 108 | MP0003183_abnormal_peptide_metabolism | 0.68608444 |
| 109 | MP0003868_abnormal_feces_composition | 0.68265634 |
| 110 | MP0000371_diluted_coat_color | 0.67385240 |
| 111 | MP0009840_abnormal_foam_cell | 0.67028995 |
| 112 | MP0001765_abnormal_ion_homeostasis | 0.66732802 |
| 113 | MP0009763_increased_sensitivity_to | 0.65989227 |
| 114 | MP0002075_abnormal_coat/hair_pigmentati | 0.65896155 |
| 115 | MP0009642_abnormal_blood_homeostasis | 0.65194828 |
| 116 | MP0003638_abnormal_response/metabolism_ | 0.64684632 |
| 117 | MP0005167_abnormal_blood-brain_barrier | 0.63534526 |
| 118 | MP0003091_abnormal_cell_migration | 0.63368522 |
| 119 | MP0003448_altered_tumor_morphology | 0.63220980 |
| 120 | MP0005085_abnormal_gallbladder_physiolo | 0.61957971 |
| 121 | MP0003172_abnormal_lysosome_physiology | 0.61897283 |
| 122 | MP0010329_abnormal_lipoprotein_level | 0.61501275 |
| 123 | MP0005381_digestive/alimentary_phenotyp | 0.60228976 |
| 124 | MP0005084_abnormal_gallbladder_morpholo | 0.60060076 |
| 125 | MP0003453_abnormal_keratinocyte_physiol | 0.59305693 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.57983569 |
| 127 | MP0004957_abnormal_blastocyst_morpholog | 0.57707650 |
| 128 | MP0003111_abnormal_nucleus_morphology | 0.55784907 |
| 129 | MP0001186_pigmentation_phenotype | 0.55157011 |
| 130 | MP0002998_abnormal_bone_remodeling | 0.53836747 |
| 131 | MP0003186_abnormal_redox_activity | 0.52488251 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal platelet volume (HP:0011876) | 4.92540403 |
| 2 | Menorrhagia (HP:0000132) | 4.87206141 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.76262817 |
| 4 | Gingival bleeding (HP:0000225) | 4.73277437 |
| 5 | IgM deficiency (HP:0002850) | 4.56444055 |
| 6 | Increased mean platelet volume (HP:0011877) | 4.51336274 |
| 7 | Myositis (HP:0100614) | 4.27221835 |
| 8 | Thrombocytosis (HP:0001894) | 4.23797667 |
| 9 | Reticulocytopenia (HP:0001896) | 4.23308140 |
| 10 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.21441846 |
| 11 | Abnormal number of erythroid precursors (HP:0012131) | 4.08813972 |
| 12 | Chronic otitis media (HP:0000389) | 4.00767032 |
| 13 | Recurrent abscess formation (HP:0002722) | 3.93854668 |
| 14 | Reduced antithrombin III activity (HP:0001976) | 3.75932689 |
| 15 | Aplastic anemia (HP:0001915) | 3.72727937 |
| 16 | Type I transferrin isoform profile (HP:0003642) | 3.63185996 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.56476153 |
| 18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.53857124 |
| 19 | Petechiae (HP:0000967) | 3.53574788 |
| 20 | Prolonged bleeding time (HP:0003010) | 3.51447989 |
| 21 | Panhypogammaglobulinemia (HP:0003139) | 3.39853562 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 3.36619503 |
| 23 | Recurrent bronchitis (HP:0002837) | 3.35603506 |
| 24 | Agammaglobulinemia (HP:0004432) | 3.29485135 |
| 25 | Meningitis (HP:0001287) | 3.27830620 |
| 26 | Abnormality of T cell physiology (HP:0011840) | 3.22418237 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.15940897 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.15940897 |
| 29 | Eczematoid dermatitis (HP:0000976) | 3.13346627 |
| 30 | Recurrent fungal infections (HP:0002841) | 3.10817186 |
| 31 | Gastrointestinal infarctions (HP:0005244) | 3.09057915 |
| 32 | Abnormal protein glycosylation (HP:0012346) | 2.99532066 |
| 33 | Abnormal glycosylation (HP:0012345) | 2.99532066 |
| 34 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.99532066 |
| 35 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.99532066 |
| 36 | Recurrent viral infections (HP:0004429) | 2.96420412 |
| 37 | Inflammation of the large intestine (HP:0002037) | 2.91437087 |
| 38 | Nasal polyposis (HP:0100582) | 2.89276264 |
| 39 | Pallor (HP:0000980) | 2.88026610 |
| 40 | Abnormality of T cells (HP:0002843) | 2.83760954 |
| 41 | Chest pain (HP:0100749) | 2.81275898 |
| 42 | Gastrointestinal inflammation (HP:0004386) | 2.80897143 |
| 43 | Recurrent skin infections (HP:0001581) | 2.79784629 |
| 44 | Abnormality of the nasal mucosa (HP:0000433) | 2.76059803 |
| 45 | Chronic obstructive pulmonary disease (HP:0006510) | 2.75462689 |
| 46 | Obstructive lung disease (HP:0006536) | 2.75462689 |
| 47 | Gingivitis (HP:0000230) | 2.74861621 |
| 48 | IgG deficiency (HP:0004315) | 2.65840616 |
| 49 | Abnormality of the prostate (HP:0008775) | 2.63891933 |
| 50 | Epistaxis (HP:0000421) | 2.63475779 |
| 51 | Orchitis (HP:0100796) | 2.62974051 |
| 52 | Cellulitis (HP:0100658) | 2.60668191 |
| 53 | Mediastinal lymphadenopathy (HP:0100721) | 2.56254137 |
| 54 | Urticaria (HP:0001025) | 2.55874947 |
| 55 | Macrocytic anemia (HP:0001972) | 2.54871107 |
| 56 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.54795700 |
| 57 | Vasculitis (HP:0002633) | 2.52811898 |
| 58 | Arterial thrombosis (HP:0004420) | 2.52327516 |
| 59 | Increased cerebral lipofuscin (HP:0011813) | 2.51572265 |
| 60 | Lymphopenia (HP:0001888) | 2.50097410 |
| 61 | B lymphocytopenia (HP:0010976) | 2.48812045 |
| 62 | Abnormality of B cell number (HP:0010975) | 2.48812045 |
| 63 | Retrobulbar optic neuritis (HP:0100654) | 2.47511466 |
| 64 | Optic neuritis (HP:0100653) | 2.47511466 |
| 65 | Hyperlipoproteinemia (HP:0010980) | 2.46622703 |
| 66 | Episodic fever (HP:0001954) | 2.46379373 |
| 67 | Vacuolated lymphocytes (HP:0001922) | 2.45502239 |
| 68 | Dysostosis multiplex (HP:0000943) | 2.44565285 |
| 69 | Abnormality of macrophages (HP:0004311) | 2.43619078 |
| 70 | Pustule (HP:0200039) | 2.43468221 |
| 71 | Increased IgM level (HP:0003496) | 2.43275369 |
| 72 | Chronic diarrhea (HP:0002028) | 2.41764388 |
| 73 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.41717263 |
| 74 | Pulmonary embolism (HP:0002204) | 2.40569893 |
| 75 | Systemic lupus erythematosus (HP:0002725) | 2.40517538 |
| 76 | Encephalitis (HP:0002383) | 2.40138295 |
| 77 | Increased serum ferritin (HP:0003281) | 2.39445078 |
| 78 | Hepatosplenomegaly (HP:0001433) | 2.38459436 |
| 79 | Type 2 muscle fiber atrophy (HP:0003554) | 2.37413490 |
| 80 | Pulmonary infiltrates (HP:0002113) | 2.37329247 |
| 81 | Poikiloderma (HP:0001029) | 2.35693174 |
| 82 | Abnormality of iron homeostasis (HP:0011031) | 2.35553518 |
| 83 | Thyroiditis (HP:0100646) | 2.31975639 |
| 84 | Colitis (HP:0002583) | 2.31854514 |
| 85 | Keratoconjunctivitis sicca (HP:0001097) | 2.31719602 |
| 86 | Muscle fiber atrophy (HP:0100295) | 2.30270829 |
| 87 | Bruising susceptibility (HP:0000978) | 2.29302447 |
| 88 | Leukocytosis (HP:0001974) | 2.29264495 |
| 89 | Chronic sinusitis (HP:0011109) | 2.27398792 |
| 90 | Lymphoma (HP:0002665) | 2.26293381 |
| 91 | Albinism (HP:0001022) | 2.25327969 |
| 92 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.24623503 |
| 93 | Interstitial pulmonary disease (HP:0006530) | 2.23554552 |
| 94 | Abnormal platelet function (HP:0011869) | 2.23323343 |
| 95 | Impaired platelet aggregation (HP:0003540) | 2.23323343 |
| 96 | Joint swelling (HP:0001386) | 2.22648572 |
| 97 | Spontaneous hematomas (HP:0007420) | 2.21951727 |
| 98 | Stomatitis (HP:0010280) | 2.19611646 |
| 99 | Osteomyelitis (HP:0002754) | 2.17738100 |
| 100 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.17642747 |
| 101 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.17642747 |
| 102 | Microcytic anemia (HP:0001935) | 2.16919796 |
| 103 | Recurrent sinusitis (HP:0011108) | 2.16718630 |
| 104 | Pancytopenia (HP:0001876) | 2.14222754 |
| 105 | Gastrointestinal stroma tumor (HP:0100723) | 2.12716106 |
| 106 | Polycythemia (HP:0001901) | 2.12318962 |
| 107 | Keratoconjunctivitis (HP:0001096) | 2.09037528 |
| 108 | Hypoproteinemia (HP:0003075) | 2.08456596 |
| 109 | Hypochromic anemia (HP:0001931) | 2.08165017 |
| 110 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.07459784 |
| 111 | Hemoptysis (HP:0002105) | 2.05843860 |
| 112 | Neutropenia (HP:0001875) | 2.05449751 |
| 113 | Amyloidosis (HP:0011034) | 2.05363876 |
| 114 | T lymphocytopenia (HP:0005403) | 2.04016899 |
| 115 | Abnormality of the common coagulation pathway (HP:0010990) | 2.03606199 |
| 116 | Abnormality of DNA repair (HP:0003254) | 2.03584160 |
| 117 | Autoimmune hemolytic anemia (HP:0001890) | 2.03218497 |
| 118 | Granulocytopenia (HP:0001913) | 2.02256325 |
| 119 | Exertional dyspnea (HP:0002875) | 2.01253815 |
| 120 | Increased density of long bones (HP:0006392) | 2.01229718 |
| 121 | Clubbing of toes (HP:0100760) | 2.01203171 |
| 122 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.99284693 |
| 123 | Joint hemorrhage (HP:0005261) | 1.99196159 |
| 124 | Myelodysplasia (HP:0002863) | 1.98499060 |
| 125 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.97224948 |
| 126 | Hypergammaglobulinemia (HP:0010702) | 1.96529025 |
| 127 | Metaphyseal cupping (HP:0003021) | 1.96277292 |
| 128 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.95864528 |
| 129 | Abnormality of T cell number (HP:0011839) | 1.95797079 |
| 130 | Purpura (HP:0000979) | 1.95698724 |
| 131 | Periodontitis (HP:0000704) | 1.95155181 |
| 132 | Severe combined immunodeficiency (HP:0004430) | 1.95030445 |
| 133 | Chromsome breakage (HP:0040012) | 1.94316498 |
| 134 | Conjunctival telangiectasia (HP:0000524) | 1.92314558 |
| 135 | 11 pairs of ribs (HP:0000878) | 1.91755001 |
| 136 | Abnormality of lateral ventricle (HP:0030047) | 1.91727528 |
| 137 | Recurrent lower respiratory tract infections (HP:0002783) | 1.90598279 |
| 138 | Anorexia (HP:0002039) | 1.89885053 |
| 139 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89863701 |
| 140 | Basal ganglia calcification (HP:0002135) | 1.89686236 |
| 141 | Hypochromic microcytic anemia (HP:0004840) | 1.89435356 |
| 142 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.89058033 |
| 143 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.88635661 |
| 144 | Restrictive lung disease (HP:0002091) | 1.88190705 |
| 145 | Increased IgE level (HP:0003212) | 1.87910482 |
| 146 | Hemorrhage of the eye (HP:0011885) | 1.84488408 |
| 147 | Arthralgia (HP:0002829) | 1.84449804 |
| 148 | Vertigo (HP:0002321) | 1.84283954 |
| 149 | Malnutrition (HP:0004395) | 1.83664503 |
| 150 | Emphysema (HP:0002097) | 1.81164549 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.79421550 |
| 2 | NME2 | 3.48212847 |
| 3 | KIT | 3.02872536 |
| 4 | TXK | 2.66395855 |
| 5 | STK16 | 2.65986218 |
| 6 | IRAK4 | 2.47620093 |
| 7 | BLK | 2.38974531 |
| 8 | BTK | 2.37045042 |
| 9 | TNIK | 2.27768333 |
| 10 | IKBKE | 2.14339912 |
| 11 | PRPF4B | 2.07083227 |
| 12 | IRAK3 | 1.88677740 |
| 13 | ZAP70 | 1.88406139 |
| 14 | TBK1 | 1.86143855 |
| 15 | PIM2 | 1.85927422 |
| 16 | EIF2AK3 | 1.81958040 |
| 17 | MUSK | 1.79940044 |
| 18 | FLT3 | 1.78621997 |
| 19 | CSF1R | 1.74004088 |
| 20 | JAK3 | 1.69406868 |
| 21 | NLK | 1.67585209 |
| 22 | FGR | 1.62935620 |
| 23 | SYK | 1.62230623 |
| 24 | TRIB3 | 1.61311661 |
| 25 | MAP3K12 | 1.59490228 |
| 26 | * TEC | 1.59454144 |
| 27 | CDK19 | 1.56268291 |
| 28 | MAP3K14 | 1.55657253 |
| 29 | TGFBR2 | 1.55549937 |
| 30 | TYK2 | 1.48781700 |
| 31 | IKBKB | 1.47723478 |
| 32 | BMX | 1.45853747 |
| 33 | EEF2K | 1.42594952 |
| 34 | TAOK1 | 1.36932486 |
| 35 | MAP2K3 | 1.35756115 |
| 36 | MAP3K3 | 1.35683879 |
| 37 | FES | 1.34011918 |
| 38 | ADRBK2 | 1.33401699 |
| 39 | TGFBR1 | 1.33119003 |
| 40 | VRK1 | 1.26480023 |
| 41 | TAOK3 | 1.26141196 |
| 42 | MKNK2 | 1.24793050 |
| 43 | LYN | 1.24325965 |
| 44 | RPS6KB2 | 1.21659118 |
| 45 | EPHB1 | 1.21535403 |
| 46 | ACVR1B | 1.21247828 |
| 47 | MKNK1 | 1.20756776 |
| 48 | BMPR2 | 1.16162423 |
| 49 | LCK | 1.16014851 |
| 50 | MAP3K11 | 1.14701165 |
| 51 | KDR | 1.13473771 |
| 52 | TLK1 | 1.12109023 |
| 53 | PIM1 | 1.10530881 |
| 54 | PDK1 | 1.10206744 |
| 55 | CLK1 | 1.07153696 |
| 56 | JAK2 | 1.04906843 |
| 57 | EIF2AK2 | 1.03577018 |
| 58 | WEE1 | 1.00847204 |
| 59 | TIE1 | 1.00823748 |
| 60 | PDPK1 | 0.99682378 |
| 61 | TNK2 | 0.99391949 |
| 62 | CAMKK2 | 0.98670923 |
| 63 | MAP3K1 | 0.98540208 |
| 64 | GRK6 | 0.95106204 |
| 65 | MATK | 0.93976327 |
| 66 | RPS6KA4 | 0.93651357 |
| 67 | PTK2B | 0.91361121 |
| 68 | HCK | 0.90792277 |
| 69 | CDC42BPA | 0.89645951 |
| 70 | DYRK3 | 0.89413272 |
| 71 | MARK2 | 0.88866303 |
| 72 | SIK1 | 0.88738906 |
| 73 | ERN1 | 0.87576591 |
| 74 | SIK2 | 0.86747514 |
| 75 | MAPK12 | 0.85945311 |
| 76 | SMG1 | 0.85289810 |
| 77 | MARK3 | 0.84865253 |
| 78 | ITK | 0.83607099 |
| 79 | TESK2 | 0.82538841 |
| 80 | CDK8 | 0.81881627 |
| 81 | MAP2K6 | 0.79334539 |
| 82 | LRRK2 | 0.78691247 |
| 83 | STK10 | 0.76597498 |
| 84 | FGFR4 | 0.74921758 |
| 85 | PRKD2 | 0.73840926 |
| 86 | IRAK2 | 0.73160368 |
| 87 | TAOK2 | 0.72169768 |
| 88 | PRKG2 | 0.72045165 |
| 89 | RET | 0.71972920 |
| 90 | MYLK | 0.69432517 |
| 91 | PKN2 | 0.69244492 |
| 92 | KSR2 | 0.68609170 |
| 93 | CDK7 | 0.67614414 |
| 94 | CHUK | 0.65883689 |
| 95 | FYN | 0.65788946 |
| 96 | CSK | 0.63935938 |
| 97 | CAMK1 | 0.63758212 |
| 98 | SRPK1 | 0.63181179 |
| 99 | CCNB1 | 0.62633660 |
| 100 | MAPKAPK5 | 0.62633616 |
| 101 | MAPK11 | 0.62000952 |
| 102 | HIPK2 | 0.60988539 |
| 103 | SIK3 | 0.60383221 |
| 104 | RIPK4 | 0.59062046 |
| 105 | PRKCQ | 0.57644526 |
| 106 | YES1 | 0.57476297 |
| 107 | JAK1 | 0.55733248 |
| 108 | FGFR3 | 0.55387225 |
| 109 | ATR | 0.53768778 |
| 110 | MAPKAPK3 | 0.52766974 |
| 111 | MAPK4 | 0.52344648 |
| 112 | TRPM7 | 0.52185113 |
| 113 | PTK6 | 0.51860460 |
| 114 | BMPR1B | 0.51515779 |
| 115 | MST4 | 0.51227333 |
| 116 | RPS6KA6 | 0.48791929 |
| 117 | EIF2AK1 | 0.48145898 |
| 118 | GRK5 | 0.47438068 |
| 119 | PIK3CG | 0.47272354 |
| 120 | MAPK7 | 0.47078520 |
| 121 | MAP3K2 | 0.46821836 |
| 122 | IRAK1 | 0.45029447 |
| 123 | CDK4 | 0.44499322 |
| 124 | RPS6KA5 | 0.44304905 |
| 125 | GRK1 | 0.43141239 |
| 126 | PRKD1 | 0.41395714 |
| 127 | MAPKAPK2 | 0.40594866 |
| 128 | MAP3K10 | 0.40143126 |
| 129 | MAP3K7 | 0.39708654 |
| 130 | CAMKK1 | 0.39305147 |
| 131 | RPS6KL1 | 0.38746527 |
| 132 | RPS6KC1 | 0.38746527 |
| 133 | SGK3 | 0.38081830 |
| 134 | MAP3K13 | 0.38064044 |
| 135 | STK24 | 0.37283059 |
| 136 | ZAK | 0.36225977 |
| 137 | MAP3K5 | 0.36047809 |
| 138 | STK4 | 0.35638422 |
| 139 | CDK12 | 0.35481670 |
| 140 | BUB1 | 0.34597151 |
| 141 | BRSK2 | 0.33302788 |
| 142 | MAP3K6 | 0.32322273 |
| 143 | BCKDK | 0.32143856 |
| 144 | AURKB | 0.31865046 |
| 145 | MAP2K2 | 0.31690019 |
| 146 | EPHA3 | 0.31672240 |
| 147 | PRKCD | 0.26972000 |
| 148 | PAK1 | 0.26779470 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.49588937 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.22890143 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.21666902 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.65078990 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.22008979 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.20317577 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.06689771 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.04229688 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.99837526 |
| 10 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.94332585 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.90800093 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.88552085 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.86479026 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.85617537 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.84329939 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.74329426 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.73850387 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.73175224 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.69345726 |
| 20 | RNA polymerase_Homo sapiens_hsa03020 | 1.64991069 |
| 21 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.64039673 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.60399716 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.60232350 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.60081406 |
| 25 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.59428512 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.54050107 |
| 27 | Protein export_Homo sapiens_hsa03060 | 1.50201765 |
| 28 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.47452859 |
| 29 | Spliceosome_Homo sapiens_hsa03040 | 1.39824110 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.38951021 |
| 31 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.38150348 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34412772 |
| 33 | Proteasome_Homo sapiens_hsa03050 | 1.34001295 |
| 34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.33998827 |
| 35 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.24977076 |
| 36 | Phagosome_Homo sapiens_hsa04145 | 1.22468113 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.21886823 |
| 38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.21656108 |
| 39 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.20292305 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17862942 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.16598935 |
| 42 | Asthma_Homo sapiens_hsa05310 | 1.12179712 |
| 43 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.10922919 |
| 44 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.06569501 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 1.05714512 |
| 46 | Malaria_Homo sapiens_hsa05144 | 1.05334226 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.04699167 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 1.02973178 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.00547428 |
| 50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.99409301 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.98655392 |
| 52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.95597319 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93250745 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 0.92957998 |
| 55 | Purine metabolism_Homo sapiens_hsa00230 | 0.92843469 |
| 56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.92624163 |
| 57 | Shigellosis_Homo sapiens_hsa05131 | 0.92556949 |
| 58 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.92547321 |
| 59 | RNA degradation_Homo sapiens_hsa03018 | 0.89318107 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88937447 |
| 61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.88852497 |
| 62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.87983184 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.87928302 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 0.84908775 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.83988209 |
| 66 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.82081793 |
| 67 | Basal transcription factors_Homo sapiens_hsa03022 | 0.81430617 |
| 68 | Hepatitis B_Homo sapiens_hsa05161 | 0.81252162 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81182593 |
| 70 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.80153063 |
| 71 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.80051780 |
| 72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79994245 |
| 73 | Apoptosis_Homo sapiens_hsa04210 | 0.79579317 |
| 74 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.79123783 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.78890837 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78590399 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78503459 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.78313958 |
| 79 | Tuberculosis_Homo sapiens_hsa05152 | 0.76768595 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75999886 |
| 81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74473048 |
| 82 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.73449314 |
| 83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72423405 |
| 84 | Cell cycle_Homo sapiens_hsa04110 | 0.72123934 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72095499 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70478744 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68532318 |
| 88 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68373340 |
| 89 | Salmonella infection_Homo sapiens_hsa05132 | 0.67226761 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67018240 |
| 91 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.66016628 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.65939030 |
| 93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64643037 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64585621 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64508307 |
| 96 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63429186 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63203543 |
| 98 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.62833460 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62416951 |
| 100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61103623 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60558486 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60131225 |
| 103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59029899 |
| 104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58533393 |
| 105 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57523926 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57373117 |
| 107 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57227446 |
| 108 | Hepatitis C_Homo sapiens_hsa05160 | 0.55349962 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | 0.53243124 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.52300921 |
| 111 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51856939 |
| 112 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51504203 |
| 113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49580458 |
| 114 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49573060 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48653512 |
| 116 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.47096820 |
| 117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45966241 |
| 118 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45164810 |
| 119 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.44433194 |
| 120 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44386281 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.44238252 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43298118 |
| 123 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42924302 |
| 124 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41574487 |
| 125 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41371995 |
| 126 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41298101 |
| 127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41097576 |
| 128 | RNA transport_Homo sapiens_hsa03013 | 0.39819941 |
| 129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38794057 |
| 130 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38531007 |
| 131 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38150754 |
| 132 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36762927 |
| 133 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36101523 |
| 134 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34545189 |
| 135 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34503075 |
| 136 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33598705 |
| 137 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32994568 |
| 138 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.32684692 |
| 139 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32630741 |
| 140 | Thyroid cancer_Homo sapiens_hsa05216 | 0.31329548 |
| 141 | Viral myocarditis_Homo sapiens_hsa05416 | 0.29824841 |
| 142 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.28357365 |

